Maria Rosario G. Araneta

Maria Rosario G. Araneta

Auto-generated profile, based on publicly available information

Maria Rosario G. Araneta

University of California, San Diego, San Diego, California (M.R.G.)

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Obesity Research
Verified
Journal Article
Closed access
PDF file
MAMaria Rosario G. Araneta
Maria Rosario G. Araneta
EBElizabeth Barrett‐Connor
Elizabeth Barrett‐Connor

9 February 2015 in Diabetes Care
Verified
Journal Article
Open access
PDF file
MAMaria Rosario G. Araneta
Maria Rosario G. Araneta
AKAlka M. Kanaya
Alka M. Kanaya
WHWilliam C. Hsu
William C. Hsu
HCHealani K. Chang
Healani K. Chang
AGAndrew Grandinetti
Andrew Grandinetti
WFWilfred Y. Fujimoto
Wilfred Y. Fujimoto
OBJECTIVE: Asian Americans manifest type 2 diabetes at low BMI levels but may not undergo diagnostic testing for diabetes if the currently recommended BMI screening cut point of ≥25 kg/m2 is followed. We aimed to ascertain an appropriate lower BMI cut point among Asian-American adults without a prior diabetes diagnosis. RESEARCH DESIGN AND METHODS: We consolidated data from 1,663 participants, ages ≥45 years, without a prior diabetes diagnosis, from population- and community-based studies, including the Mediators of Atherosclerosis in South Asians Living in America study, the North Kohala Study, the Seattle Japanese American Community Diabetes Study, and the University of California San Diego Filipino Health Study. Clinical measures included a 2-h 75-g oral glucose tolerance test, BMI, and glycosylated hemoglobin (HbA1c). RESULTS: Mean age was 59.7 years, mean BMI was 25.4 kg/m2, 58% were women, and type 2 diabetes prevalence (American Diabetes Association 2010 criteria) was 16.9%. At BMI ≥25 kg/m2, sensitivity (63.7%), specificity (52.8%), and Youden index (0.16) values were low; limiting screening to BMI ≥25 kg/m2 would miss 36% of Asian Americans with type 2 diabetes. For screening purposes, higher sensitivity is desirable to minimize missing cases, especially if the diagnostic test is relatively simple and inexpensive. At BMI ≥23 kg/m2, sensitivity (84.7%) was high in the total sample and by sex and Asian-American subgroup and would miss only ∼15% of Asian Americans with diabetes. CONCLUSIONS: The BMI cut point for identifying Asian Americans who should be screened for undiagnosed type 2 diabetes should be <25 kg/m2, and ≥23 kg/m2 may be the most practical.

4 January 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
AKAlka M. Kanaya
Alka M. Kanaya
AHAnn W Hsing
Ann W Hsing
SPSela V. Panapasa
Sela V. Panapasa
NKNamratha R. Kandula
Namratha R. Kandula
MAMaria Rosario G. Araneta
Maria Rosario G. Araneta
YHYuling Hong
Yuling Hong
This special article summarizes findings from a 3-day multidisciplinary workshop, hosted by the National Institutes of Health to identify research opportunities for advancing prevention and care an... Asian Americans (AsA), Native Hawaiians, and Pacific Islanders (NHPI) comprise 7.7% of the U.S. population, and AsA have had the fastest growth rate since 2010. Yet the National Institutes of Healt...

14 April 2003 in Birth Defects Research Part A: Clinical and Molecular Teratology
Verified
Journal Article
Closed access
PDF file
MAMaria Rosario G. Araneta
Maria Rosario G. Araneta
KSKaren M. Schlangen
Karen M. Schlangen
LELarry D. Edmonds
Larry D. Edmonds
DDDaniel A. Destiche
Daniel A. Destiche
RMRuth D. Merz
Ruth D. Merz
GGGregory Gray
Gregory Gray

1 December 2009 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
MAMaria Rosario G Araneta
Maria Rosario G Araneta
DMDenise von Mühlen
Denise von Mühlen
EBElizabeth Barrett-Connor
Elizabeth Barrett-Connor
We evaluated sex differences in the prospective association between adiponectin with BMD, bone loss, and fractures. Adiponectin, an adipose-derived protein with insulin-sensitizing properties, is also expressed in bone-forming cells. Conflicting results and sex differences in the adiponectin-BMD association have been reported in cross-sectional studies. Serum adiponectin was measured in fasting blood samples obtained in 1984–1987 in 447 postmenopausal women (mean age: 76 yr) and 484 men (mean age: 75 yr). Four years later, BMD was measured at the midshaft radius by single photon absorptiometry and at the femoral neck, total hip, and lumbar spine by DXA. In 1992–1996, axial BMD was remeasured in 261 women and 264 men. Multivariable analysis adjusted for age, weight, calcium intake, type 2 diabetes, alcohol intake, and exercise. Among women, adiponectin was inversely associated with BMD at the femoral neck (β = −0.002, p = 0.007), total hip (β = −0.002, p = 0.009), lumbar spine (β = −0.003, p = 0.008), and midshaft radius (β = −0.002, p = 0.01) after 4.4 yr and at the femoral neck and total hip 8.6 yr later. Among men, adiponectin was inversely associated with BMD at the femoral neck, (β = −0.002, p = 0.03), total hip (β = −0.004, p < 0.001), and midshaft radius (β = −0.003, p < 0.001) after 4.4 yr and at the hip 8.6 yr later. Adiponectin was not associated with 4-yr bone loss in either sex but was associated with vertebral fractures (adjusted OR: 1.13; 95% CI: 1.08–1.23; p = 0.009) among men only. Adiponectin was inversely associated with BMD; however, sex differences were observed by anatomical site and with regards to vertebral fractures.

10 September 2010 in Diabetes Care
Verified
Journal Article
Open access
MAMaria Rosario G. Araneta
Maria Rosario G. Araneta
AGAndrew Grandinetti
Andrew Grandinetti
HCHealani K. Chang
Healani K. Chang
OBJECTIVE: To examine the sensitivity and specificity of A1C ≥6.5% to diagnose diabetes among Filipino Americans, Japanese Americans, and Native Hawaiians. RESEARCH DESIGN AND METHODS: This was a cross-sectional study among middle-aged adults without prior diagnosis of type 2 diabetes who completed a 2-h 75-g oral glucose tolerance test (OGTT) and A1C measures. RESULTS: The 933 participants had a mean age of 54.2 years, and 73% were women. A total of 425 (45.5%) subjects had impaired fasting glucose or impaired glucose tolerance, 145 (15.5%) had type 2 diabetes (by OGTT), and 83 (8.9%) had A1C ≥6.5%. The sensitivity and specificity of A1C ≥6.5% to define diabetes (by OGTT) was 40.0 and 96.8% and 68.9 and 95.3%, respectively (by fasting plasma glucose only). However, (64.8%) of Filipino and Japanese subjects with diabetes had isolated postchallenge hyperglycemia; AIC ≥6.5% sensitivity and specificity was 19.1 and 92.1%, respectively, to define isolated postchallenge hyperglycemia in the total sample. CONCLUSIONS: A1C ≥6.5% had low sensitivity and may delay diagnosis of type 2 diabetes without OGTT. This limitation is exacerbated by isolated postchallenge hyperglycemia in Asian Americans.